Science Daily

1. Changing when you eat dramatically reduced Crohn’s disease symptoms

   A new clinical trial suggests that changing when you eat could make a meaningful difference for people living with Crohn’s disease. Researchers found that time-restricted feeding, a form of intermittent fasting that limits meals to an 8-hour daily window, reduced disease activity by 40% and cut abdominal discomfort in half over 12 weeks. Participants also lost weight and showed healthier inflammation and immune markers, even though they did not reduce calories or change what they ate.

2. Life may have started as sticky goo clinging to rocks

   Life may have started in sticky, rock-hugging gels rather than inside cells. Researchers suggest these primitive, biofilm-like materials could trap and concentrate molecules, giving early chemistry a protected space to grow more complex. Within these gels, the first hints of metabolism and self-replication may have emerged.

3. Interstellar comet 3I/ATLAS is spraying water across the solar system

   For millions of years, a frozen wanderer drifted between the stars before slipping into our solar system as 3I/ATLAS—only the third known interstellar comet ever spotted. When scientists turned NASA’s Swift Observatory toward it, they caught the first-ever hint of water from such an object, detected through a faint ultraviolet glow of hydroxyl gas. Even more surprising, the comet was blasting out water at a rate of about 40 kilograms per second while still far from the Sun—much farther than where most comets “switch on.”

4. Blockbuster weight loss drugs like Ozempic deliver big results but face big questions

   Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide (Victoza and Saxenda) can lead to substantial weight loss in people with obesity. But while the results are impressive, researchers caution that most trials were funded by drugmakers, long term safety data are still limited, and side effects such as nausea are common.

5. Just 5 weeks of brain training may protect against dementia for 20 years

   A simple brain-training program that sharpens how quickly older adults process visual information may have a surprisingly powerful long-term payoff. In a major 20-year study of adults 65 and older, those who completed five to six weeks of adaptive “speed of processing” training — along with a few booster sessions — were significantly less likely to develop dementia, including Alzheimer’s disease, even two decades later. Participants who received the boosted speed training had a 25% lower dementia risk compared to those who received no training, making it the only intervention in the trial to show such a lasting protective effect.